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 Objectives 
 Extracorporeal shock wave lithotripsy (ESWL) alone 
is the treatment of choice for approximately 90–95% of all 
stone-forming patients, or in combination with other 
procedures in the remaining stone patients. Depending 
on the size, location and composition of the stones and 
the anatomic abnormalities of the collecting system, the 
presence of residual stone material after ESWL is com-
mon  [1, 2] . An increase in stone formation and the growth 
of residual fragments after lithotripsy due to urine hyper-
saturation has been reported  [3] .
 Changes in renal function after ESWL have also been 
documented, with increased tubular enzymes, glomeru-
lar protein excretion in urine and hypercalciuria seen 
from 1 up to 5 days after primary ESWL  [4–7] . The tubu-
lar damage may be explained by ischemic anoxia of tubu-
lar cells after lithotripsy and induced bleeding of the re-
nal parenchyma, followed by generation of free radicals 
and lipid peroxidation resulting in toxicity to tubular 
cells  [8] .
 The tubular epithelium plays an important role in re-
nal calcium clearance. After the glomerular filtration of 
about 60% of plasma calcium, only 1–2% of the filtrated 
calcium is eliminated with the urine because of a highly 
specific tubular reabsorption process  [9] . The calcium/
creatinine clearance ratio (Ca/CrCl ratio) strongly cor-
relates with the tubular function of calcium reabsorption. 
Ca/CrCl ratios of 0.01 are associated with normal renal 
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 Abstract 
 Introduction: Extracorporeal shock wave lithotripsy (ESWL) 
is the standard stone treatment. Increased excretion of tubu-
lar enzymes and hypercalciuria has been reported after 
ESWL. We investigated the importance of renally induced 
hypercalciuria after ESWL.  Material and Methods: 30 calci-
um oxalate stoneformers (23 men, 7 women), mean age 53.3 
(range 30–71) years, were evaluated prospectively. Plasma 
calcium and creatinine concentrations and 8-hour overnight 
urine were measured before ESWL and on the 1st and 2nd 
days after ESWL. To estimate the changes of tubular reab-
sorption, the calcium/creatinine clearance ratios were calcu-
lated.  Results: Hypercalciuria ( 1 5 mmol/24 h) was seen in 
5/30 (16.7%) before, in 12/30 (40.0%) on day 1 and in 13/30 
(43.3%) on day 2 after ESWL. The mean plasma levels of cal-
cium were significantly decreased from 2.36 mmol/l before 
to 2.28 mmol/l on day 2 after ESWL (p ! 0.01). The mean cal-
cium/creatinine clearance ratio was significantly increased 
from 0.012 before to 0.019 after ESWL (p ! 0.01). Before and 
on day 2 after ESWL, the calcium/creatinine clearance ratio 
was significantly correlated with the age of the patients (r = 
0.33, p ! 0.04).  Conclusion: Our data show an age-related 
significantly increased urine calcium excretion after ESWL 
possibly due to decreased tubular calcium reabsorption. 
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tubular function  [10] . Thus, tubular shock wave-induced 
damage might correlate with changes of renal clearance 
of calcium. We investigated the clinical importance of 
renally induced hypercalciuria in calcium-oxalate stone-
formers after primary ESWL. 
 Materials and Methods 
 In a prospective study, 30 calcium-oxalate-forming patients 
(23 men, 7 women) were evaluated. The mean age of the patients 
was 53.3  8 12.4 years. All patients had normal creatinine clear-
ance, normal intravenous pyelograms and normal serum values 
of parathyroid hormones. The urine was sterile in all patients. 
The ESWL was performed with the lithotriptors MFL 5000 and 
Siemens Multiline. Stone size, stone location, applied shock waves 
and stone analysis of the treated patients are given in  table 1 . 
Urine    samples    from    8-hour    overnight    collection    (10    p.m.    to  
6 a.m.) were measured before ESWL and on day 1 (up to 18 h after 
ESWL) and day 2 (up to 42 h after ESWL). The measurements 
from the urine samples were extrapolated to a 24-hour value. Flu-
id intake was not restricted. Patients received the normal hospital 
diet and recorded their daily dietary intake ( table 2 ).
 Means were compared by Wilcoxon’s test and correlation were 
calculated by Pearson’s correlation coefficient.
 Results 
 Hypercalciuria ( 1 5 mmol/24 h) was seen in 5/30 
(16.7%) patients before ESWL, in 12/30 (40.0%) on day 1 
(up to 18 h after ESWL) and in 13/30 (43.3%) on day 2 (up 
to 42 h after ESWL) ( table 3 ). There were stable creatinine 
clearance values after ESWL in comparison to the values 
before ( table 4 ). The mean values of calculated 24-hour 
urine calcium excretion increased significantly from 3.57 
mmol/24 h before ESWL to 5.09  8 3.0 mmol/24 h on day 
1 (p  ! 0.01) and to 5.23 mmol/24 h on day 2 after ESWL 
(p  ! 0.01;  table 3 ). Mean plasma levels of calcium were 
significantly decreased from 2.36 mmol/l before ESWL 
to 2.28 mmol/l on day 2 after ESWL (p  ! 0.01). The mean 
calcium/creatinine clearance ratio was significantly in-
creased from 0.012 before ESWL to 0.019 after ESWL 
(p  ! 0.01;  table 4 ). A significant correlation of the calci-
um/creatinine clearance ratio with age was seen before 
ESWL (r = 0.33,p  ! 0.037) and on day 2 after treatment 
(r = 0.33, p ! 0.040) ( fig. 1 ).
 Discussion 
 ESWL, due to the high efficiency and low morbidity 
rate of the HM3 lithotriptor, became the treatment of 
choice for most renal stones after 1980  [11] . With the 
high number of residual fragments after primary ESWL, 
Table 1. Stone size, stone location, applied shock waves and stone 
analysis of the treated patients
Mean stone size 8.9 ! 7.4 (8 4.8) mm
Caliceal stones 20 patients
Renal pelvic stones 10 patients
Mean applied shock waves 2,681 (8 849) waves
Table 2. Daily dietary intake of the patients with the code of diet
Patient No. Day before
ESWL
Day of
ESWL
1st day after
ESWL
1 1 3 5
2 1 2 5
3 4 2 4
4 4 3 5
5 1 3 5
6 1 1 5
7 4 3 5
8 4 3 5
9 1 3 5
10 1 3 5
11 5 3 5
12 1 2 5
13 1 2 5
14 1 3 5
15 1 2 5
16 2 1 1
17 1 2 5
18 4 2 1
19 5 3 1
20 1 2 2
21 5 6 5
22 3 5 1
23 5 6 5
24 5 6 5
25 4 6 5
26 6 3 5
27 5 5 6
28 1 3 5
29 1 3 1
30 1 3 1
The diet codes following are given in the order breakfast/
lunch/dinner. 1 = Continental breakfast/soup/soup; 2 = fasting/
fasting/fasting; 3 = fasting/fasting/dinner; 4 = continental break-
fast/lunch/soup; 5 = continental breakfast/lunch/dinner; 6 = fast-
ing/lunch/dinner.
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further treatment or other measures are needed to ren-
der the patients stone free  [3, 12–14] . Retreatment rates 
after primary ESWL are significantly correlated with 
stone burden and location. Stone-free rates are about 63, 
73 and 71% for lower, middle and upper caliceal stones 
 [15] .
 In our study, early significant changes in the 8-hour 
overnight urine collection after ESWL were measurable 
under conditions of a nonstandardized diet. The number 
of calcium-oxalate stoneformers with pathological calci-
um urine excretion increased significantly from 5/30 be-
fore ESWL to 13/30 42 h after ESWL in the study group. 
With a stable creatinine clearance after ESWL, the cal-
cium/creatinine clearance ratios were significantly in-
creased indicating decreased tubular reabsorption. The 
calcium plasma levels were also significantly decreased 
over the investigated period. Hypercalciuria due to high-
er oral calcium intake therefore appears to be unlikely. 
Thus, it seems that tubular dysfunction after ESWL leads 
to hypercalciuria because of a decreased tubular reab-
sorption of the filtrated calcium.
 Several studies have demonstrated that an oral citrate 
treatment after ESWL can decrease the regrowth of re-
sidual fragments. These studies showed a 75% reduction 
in size in residual fragments and a 28.5% reduction in 
stone recurrences under treatment with oral citrate  [16, 
17] . Oral citrate elevates urinary pH values, reduces cal-
cium excretion, inhibits the urine calcium binding ca-
pacity and increases the urinary citrate excretion. There-
fore, calcium oxalate stone forming patients who can be 
expected to undergo repeated lithotripsy for a large stone 
mass might benefit from early metaphylaxis with oral ci-
trate treatment in order to reduce the early regrowth of 
residual fragments related to ESWL-induced hypercalci-
uria.
 The tubular effects as expressed by hypercalciuria 
were more pronounced in older than in younger patients. 
In    our    study,   patients   over   55   years   of   age   had   a   high-
Table 3. Plasma calcium and calculated 24-hour calcium urine 
excretion (mean 8 SD)
Plasma calcium 
mmol/l
Calcium in urine 
mmol/24 h
Before ESWL 2.3680.12 3.5782.3
1st day (18 h) after ESWL 2.3280.10 5.0983.0**
2nd day (42 h) after ESWL 2.2880.10* 5.2383.3**
Wilcoxon’s test comparing the values before and after ESWL. 
* p < 0.05, ** p < 0.01.
Table 4. Urine volume, creatinine clearance and calcium/creatinine clearance ratio (mean 8 SD)
Urine volume
ml
Creatinine clearance
ml/min
Calcium/creatinine
clearance ratio
Before ESWL 5798372 77.4823.6 0.01280.007
1st day (18 h) after ESWL 9748573* 78.3830.7 0.01980.011*
2nd (42 h) after ESWL 8158350* 79.8830.0 0.01980.014*
Wilcoxon’s test comparing the values before and after ESWL. *p < 0.01.
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Calcium/creatinine clearance ratio Fig. 1. Scatter plot with correlation between the age of the patients 
and the calcium/creatinine clearance ration 42 h after ESWL (r = 
0.33; p  ! 0.04; Persons’ correlation coefficient). 
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er risk for post-lithotripsy hypercalciuria. Concerning 
ESWL-induced tubular damage, Strohmaier et al. [18] 
demonstrated that calcium antagonists (e.g. nifedipine) 
produce a protective effect. In conclusion to our data, pa-
tients over 55 years seem to have more benefit from pro-
tective agents to reduce the tubular damage after ESWL. 
Our findings might also be of relevance for the timing of 
ESWL retreatment as these should be done after the res-
toration of normal tubular function  [4, 16] .
 Conclusions 
 Our data show a significantly increased urinary cal-
cium excretion, with potential implications for early 
metaphylaxis in calcium oxalate stone-forming patients 
after primary ESWL. Furthermore, age-dependent dam-
age of tubular renal function was seen, which might be of
relevance for the timing of ESWL retreatment and the use
of protective tubular agents for patients over 55 years. 
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